LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 7 of 87
Next
>>
>
151 to 175 of 2160 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	GSK1059615	0.04	uM	LJP5	1	E06	72	hr	1657	5503	5505	0.9995	0.9993
BT-20	GSK1059615	0.04	uM	LJP5	2	E06	72	hr	1657	5192	5505	0.9430	0.9185
BT-20	GSK1059615	0.04	uM	LJP5	3	E06	72	hr	1657	5944	5505	1.0796	1.1139
BT-20	GSK1059615	0.04	uM	LJP6	1	C06	72	hr	1657	4631	5505	0.8411	0.7727
BT-20	GSK1059615	0.04	uM	LJP6	2	C06	72	hr	1657	4717	5505	0.8568	0.7950
BT-20	GSK1059615	0.04	uM	LJP6	3	C06	72	hr	1657	4794	5505	0.8707	0.8151
BT-20	GSK1904529A	0.04	uM	LJP6	1	H24	72	hr	1657	4815	5505	0.8746	0.8205
BT-20	GSK1904529A	0.04	uM	LJP6	2	H24	72	hr	1657	5104	5505	0.9270	0.8956
BT-20	GSK1904529A	0.04	uM	LJP6	3	H24	72	hr	1657	4572	5505	0.8304	0.7574
BT-20	Omipalisib	0.04	uM	LJP6	1	N06	72	hr	1657	1575	5505	0.2861	-0.0215
BT-20	Omipalisib	0.04	uM	LJP6	2	N06	72	hr	1657	1540	5505	0.2797	-0.0306
BT-20	Omipalisib	0.04	uM	LJP6	3	N06	72	hr	1657	1724	5505	0.3131	0.0172
BT-20	GSK 690693	0.04	uM	LJP5	1	F24	72	hr	1657	4701	5505	0.8539	0.7909
BT-20	GSK 690693	0.04	uM	LJP5	2	F24	72	hr	1657	4518	5505	0.8206	0.7433
BT-20	GSK 690693	0.04	uM	LJP5	3	F24	72	hr	1657	5014	5505	0.9107	0.8722
BT-20	GW843682X	0.04	uM	LJP6	1	B18	72	hr	1657	4763	5505	0.8651	0.8070
BT-20	GW843682X	0.04	uM	LJP6	2	B18	72	hr	1657	4918	5505	0.8933	0.8473
BT-20	GW843682X	0.04	uM	LJP6	3	B18	72	hr	1657	4977	5505	0.9040	0.8626
BT-20	HG-5-113-01	0.04	uM	LJP5	1	B12	72	hr	1657	5549	5505	1.0079	1.0113
BT-20	HG-5-113-01	0.04	uM	LJP5	2	B12	72	hr	1657	4928	5505	0.8951	0.8499
BT-20	HG-5-113-01	0.04	uM	LJP5	3	B12	72	hr	1657	5279	5505	0.9588	0.9411
BT-20	HG-5-88-01	0.04	uM	LJP6	1	A24	72	hr	1657	4745	5505	0.8618	0.8023
BT-20	HG-5-88-01	0.04	uM	LJP6	2	A24	72	hr	1657	4698	5505	0.8533	0.7901
BT-20	HG-5-88-01	0.04	uM	LJP6	3	A24	72	hr	1657	4464	5505	0.8108	0.7293
BT-20	Imatinib	0.04	uM	LJP6	1	N18	72	hr	1657	5508	5505	1.0004	1.0006

|<
<<
Previous
Page 7 of 87
Next
>>
>
151 to 175 of 2160 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)